Skandinaviska Enskilda Banken AB publ Invests $756,000 in LENSAR, Inc. $LNSR

by · The Cerbat Gem

Skandinaviska Enskilda Banken AB publ bought a new stake in shares of LENSAR, Inc. (NASDAQ:LNSR – Free Report) during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund bought 57,433 shares of the company’s stock, valued at approximately $756,000. Skandinaviska Enskilda Banken AB publ owned 0.48% of LENSAR as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in LNSR. Groupe la Francaise bought a new stake in LENSAR in the first quarter valued at $1,779,000. OMERS ADMINISTRATION Corp purchased a new stake in shares of LENSAR in the 1st quarter worth about $1,680,000. Geode Capital Management LLC boosted its stake in shares of LENSAR by 103.9% during the 2nd quarter. Geode Capital Management LLC now owns 219,373 shares of the company’s stock valued at $2,890,000 after purchasing an additional 111,802 shares in the last quarter. Credit Industriel ET Commercial boosted its stake in shares of LENSAR by 98.4% during the 2nd quarter. Credit Industriel ET Commercial now owns 168,600 shares of the company’s stock valued at $2,220,000 after purchasing an additional 83,600 shares in the last quarter. Finally, Goldman Sachs Group Inc. purchased a new position in shares of LENSAR during the first quarter valued at about $546,000. Hedge funds and other institutional investors own 40.15% of the company’s stock.

Analyst Ratings Changes

Several analysts have commented on LNSR shares. Weiss Ratings restated a “sell (d-)” rating on shares of LENSAR in a report on Wednesday, October 8th. Wall Street Zen raised LENSAR to a “hold” rating in a research report on Friday, November 28th. Two equities research analysts have rated the stock with a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat.com, LENSAR currently has an average rating of “Reduce” and an average price target of $15.00.

Get Our Latest Analysis on LENSAR

LENSAR Price Performance

Shares of NASDAQ LNSR opened at $10.27 on Wednesday. LENSAR, Inc. has a 1 year low of $7.13 and a 1 year high of $17.31. The firm has a 50-day moving average of $11.38 and a 200 day moving average of $12.33. The stock has a market cap of $122.62 million, a P/E ratio of -2.34 and a beta of 0.66.

LENSAR (NASDAQ:LNSR – Get Free Report) last announced its quarterly earnings data on Thursday, November 6th. The company reported ($0.31) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.08) by ($0.23). LENSAR had a negative return on equity of 737.30% and a negative net margin of 87.12%.The business had revenue of $14.32 million during the quarter, compared to analysts’ expectations of $17.75 million.

LENSAR Company Profile

(Free Report)

LENSAR, Inc, a commercial-stage medical device company, focuses on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. It offers LENSAR Laser System that incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, procedure planning, design, and precision.

Read More